'Tis the sea­son for bio­phar­ma fundrais­ing, as Cowen clos­es $493M fund

An­oth­er health­care ven­ture fund is sur­feit with cap­i­tal, as the sea­son for fundrais­ing mo­tors on amid the coro­n­avirus pan­dem­ic.

Cowen Health­care In­vest­ments (CHI), an in­vest­ment man­ag­er af­fil­i­at­ed with the in­vest­ment bank Cowen, has closed its third fund, rais­ing $493 mil­lion, a meaty $93 mil­lion above its orig­i­nal tar­get. Found­ed in 2012, CHI fo­cus­es its in­vest­ments in es­tab­lished bio­phar­ma, di­ag­nos­tics and dig­i­tal health com­pa­nies and has in­ject­ed funds in 38 pri­vate com­pa­nies thus far.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER